Des cellules souches embryonnaires humaines pour le traitement de la maladie de Parkinson ?

Anselme L. Perrier

doi:10.1051/medsci/200521111

Accueil

Tous les numéros

Volume 21 / Numéro 1 (Janvier 2005)

Med Sci (Paris), 21 1 (2005) 11-13

Références

Accès gratuit

Numéro		Med Sci (Paris) Volume 21, Numéro 1, Janvier 2005


Page(s)		11 - 13
Section		Nouvelles
DOI		https://doi.org/10.1051/medsci/200521111
Publié en ligne		15 janvier 2005

Bjorklund A, Dunnett SB, Brundin P, et al. Neural transplantation for the treatment of Parkinson’s disease. Lancet Neurol 2003; 2 : 437–45. [Google Scholar]
Perrier AL, Studer L. Making and repairing the mammalian brain : in vitro production of dopaminergic neurons. Semin Cell Dev Biol 2003; 14 : 181–9. [Google Scholar]
Lee SH, Lumelsky N, Studer L, et al. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 2000; 18 : 675–9. [Google Scholar]
Chung S, Sonntag KC, Andersson T, et al. Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. Eur J Neurosci 2002; 16 : 1829–38. [Google Scholar]
Kawasaki H, Mizuseki K, Nishikawa S, et al. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 2000; 28 : 31–40. [Google Scholar]
Barberi T, Klivenyi P, Calingasan NY, et al. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in Parkinsonian mice. Nat Biotechnol 2003; 21 : 1200–7. [Google Scholar]
Kim JH, Auerbach JM, Rodriguez-Gomez JA, et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson’s disease. Nature 2002; 418 : 50–6. [Google Scholar]
Zhang SC, Wernig M, Duncan ID, et al. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 2001; 19 : 1129–33. [Google Scholar]
Reubinoff BE, Itsykson P, Turetsky T, et al. Neural progenitors from human embryonic stem cells. Nat Biotechnol 2001; 19 : 1134–40. [Google Scholar]
Perrier AL, Tabar V, Barberi T, et al. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci USA 2004; 101 : 12543–8. [Google Scholar]
Ye W, Shimamura K, Rubenstein JL, et al. FGF and Shh signals control dopaminergic and serotoninergic cell fate in the anterior neural plate. Cell 1998; 93 : 755–66. [Google Scholar]
Lindvall O, Kokaia Z, Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders : how to make it work. Nat Med 2004; 10 (suppl) : S42–50. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.

[1] Bjorklund A, Dunnett SB, Brundin P, et al. Neural transplantation for the treatment of Parkinson’s disease. Lancet Neurol 2003; 2 : 437–45. [Google Scholar]

[2] Perrier AL, Studer L. Making and repairing the mammalian brain : in vitro production of dopaminergic neurons. Semin Cell Dev Biol 2003; 14 : 181–9. [Google Scholar]

[3] Lee SH, Lumelsky N, Studer L, et al. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 2000; 18 : 675–9. [Google Scholar]

[4] Chung S, Sonntag KC, Andersson T, et al. Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. Eur J Neurosci 2002; 16 : 1829–38. [Google Scholar]

[5] Kawasaki H, Mizuseki K, Nishikawa S, et al. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 2000; 28 : 31–40. [Google Scholar]

[6] Barberi T, Klivenyi P, Calingasan NY, et al. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in Parkinsonian mice. Nat Biotechnol 2003; 21 : 1200–7. [Google Scholar]

[7] Kim JH, Auerbach JM, Rodriguez-Gomez JA, et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson’s disease. Nature 2002; 418 : 50–6. [Google Scholar]

[8] Zhang SC, Wernig M, Duncan ID, et al. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 2001; 19 : 1129–33. [Google Scholar]

[9] Reubinoff BE, Itsykson P, Turetsky T, et al. Neural progenitors from human embryonic stem cells. Nat Biotechnol 2001; 19 : 1134–40. [Google Scholar]

[10] Perrier AL, Tabar V, Barberi T, et al. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci USA 2004; 101 : 12543–8. [Google Scholar]

[11] Ye W, Shimamura K, Rubenstein JL, et al. FGF and Shh signals control dopaminergic and serotoninergic cell fate in the anterior neural plate. Cell 1998; 93 : 755–66. [Google Scholar]

[12] Lindvall O, Kokaia Z, Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders : how to make it work. Nat Med 2004; 10 (suppl) : S42–50. [Google Scholar]